Retrospective analysis of the forty-six patients with bullous pemphigoid followed-up in our clinic


YAZİCİ S., BÜLBÜL BAŞKAN E., Tunali S., AYDOĞAN K., SARICAOĞLU H.

TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, cilt.50, sa.3, ss.114-118, 2016 (ESCI) identifier identifier

Özet

Background and Design: Bullous pemphigoid (BP) is an autoimmune disease characterised by widespread itchy plaques and subepithelial blisterings and usually affects the elderly population. Due to the chronic nature of the disease, to prevent the side effects of chronic steroid treatment, adjuvant immunosuppressive (mycophenolate mofetil, azathioprine, methotrexate) and anti-inflammatory (tetracycline, nicotinamide, dapsone) agents may be used. In this study, we retrospectively evaluated the clinical and demographic characteristics and applied treatments of 46 patients with the diagnosis of BP and compared with literature data.